糖尿病 の 腎臓 疾患 の 薬剤 療法 の 進歩: 体系 的 な レビュー
Hongli Zhang1, Jiewen Chen2, Niansong Wang1
1Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Diabetes/metabolism research and reviews
|August 23, 2025
まとめ
糖尿病性腎臓病 (DKD) の治療は,従来の方法を超えて進化しています. 新しい薬と伝統的な中国医学 (TCM) は,糖尿病患者の腎臓と心臓血管の改善のための有望なマルチターゲットの戦略を提供します.
科学分野:
- 腎臓科
- 内分泌学
- 薬理学について
背景:
- 糖尿病性腎臓病 (DKD) は糖尿病の主要な合併症であり,末期腎臓病と著しい死亡率につながる.
- レニン- 血管新生系を標的とした現在の治療は,腎不全の残留リスクを残します.
- DKDを効果的に管理するには新しい治療方法が必要です.
研究 の 目的:
- 糖尿病性腎臓病の新たな治療戦略を 検討する.
- 新薬学的薬剤と中国伝統医学 (TCM) の可能性を強調する.
- DKD管理における多目的アプローチの利点を強調する.
主な方法:
- DKDの治療に関する現在の文献のレビュー.
- GLP-1受容体アゴニスト,SGLT-2阻害体,その他を含む新薬クラスの分析.
- DKDにおけるTCMの役割と発展する枠組みの探求
主要な成果:
- SGLT-2阻害剤やGLP-1受容体アゴニストのような新薬は腎臓に重大な効果を示しています.
- 非ステロイドミネラルコルチコイド受容体抗体および選択性エンドセリン受容体抗体も有効性を示しています.
- 伝統的中国医学 (TCM) は DKDの治療に 有望な総合的で多目的的なアプローチを示しています
結論:
- 新しい薬剤療法とTCMを組み合わせた多目的戦略は,DKDの変革の可能性を秘めています.
- これらのアプローチは,DKDの進行を緩和し,心血管の健康を改善し,医療の負担を軽減することができます.
- 将来の研究は,標準化された試験,長期のTCMの安全性,および最適な患者の結果のためのパーソナライズされたレジメントに焦点を当てるべきです.
関連する概念動画
01:28Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
01:15Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
01:25Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
01:22Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483